Arbutus Biopharma Corp (ABUS)
2.71
+0.03
(+1.12%)
USD |
NASDAQ |
May 03, 16:00
2.715
0.00 (0.00%)
After-Hours: 20:00
Arbutus Biopharma Max Drawdown (5Y): 96.69% for April 30, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
Date | Value |
---|---|
April 30, 2024 | 96.69% |
March 31, 2024 | 96.69% |
February 29, 2024 | 96.69% |
January 31, 2024 | 96.69% |
December 31, 2023 | 96.69% |
November 30, 2023 | 96.69% |
October 31, 2023 | 96.69% |
September 30, 2023 | 96.69% |
August 31, 2023 | 96.69% |
July 31, 2023 | 96.69% |
June 30, 2023 | 96.69% |
May 31, 2023 | 96.69% |
April 30, 2023 | 96.69% |
March 31, 2023 | 96.69% |
February 28, 2023 | 96.69% |
January 31, 2023 | 96.69% |
December 31, 2022 | 96.69% |
November 30, 2022 | 96.69% |
October 31, 2022 | 96.69% |
September 30, 2022 | 96.69% |
August 31, 2022 | 96.69% |
July 31, 2022 | 96.69% |
June 30, 2022 | 96.69% |
May 31, 2022 | 96.69% |
April 30, 2022 | 96.69% |
Date | Value |
---|---|
March 31, 2022 | 96.69% |
February 28, 2022 | 96.69% |
January 31, 2022 | 96.69% |
December 31, 2021 | 96.69% |
November 30, 2021 | 96.69% |
October 31, 2021 | 96.69% |
September 30, 2021 | 96.69% |
August 31, 2021 | 96.69% |
July 31, 2021 | 96.69% |
June 30, 2021 | 96.69% |
May 31, 2021 | 96.69% |
April 30, 2021 | 96.69% |
March 31, 2021 | 96.69% |
February 28, 2021 | 96.69% |
January 31, 2021 | 96.69% |
December 31, 2020 | 96.69% |
November 30, 2020 | 96.69% |
October 31, 2020 | 96.69% |
September 30, 2020 | 96.69% |
August 31, 2020 | 96.69% |
July 31, 2020 | 96.69% |
June 30, 2020 | 96.69% |
May 31, 2020 | 96.69% |
April 30, 2020 | 96.69% |
March 31, 2020 | 96.69% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
94.07%
Minimum
May 2019
96.69%
Maximum
Oct 2019
96.53%
Average
96.69%
Median
Oct 2019
Max Drawdown (5Y) Benchmarks
Moderna Inc | 85.65% |
Pacira BioSciences Inc | 70.10% |
Chimerix Inc | 97.79% |
Karyopharm Therapeutics Inc | 97.56% |
Corvus Pharmaceuticals Inc | 95.28% |
Max Drawdown (5Y) Related Metrics
Alpha (5Y) | -24.57 |
Beta (5Y) | 2.047 |
Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 96.38% |
Historical Sharpe Ratio (5Y) | -0.0182 |
Historical Sortino (5Y) | -0.0401 |
Monthly Value at Risk (VaR) 5% (5Y Lookback) | 33.06% |